Endocrine Therapy and Its Effect on Sexual Function

Gespeichert in:

Bibliographische Detailangaben
Zeitschriftentitel:	American Society of Clinical Oncology Educational Book
Personen und Körperschaften:	Goldfarb, Shari
In:	American Society of Clinical Oncology Educational Book, 2015, 35, S. e575-e581
Format:	E-Article
Sprache:	Englisch
veröffentlicht:	American Society of Clinical Oncology (ASCO)
Schlagwörter:	General Medicine

Details
Zusammenfassung:	<jats:p>KEY POINTS</jats:p><jats:p>Breast cancer and its treatment, especially endocrine therapy, can cause sexual dysfunction, which is often multifactorial in nature with both a physical and mental component.</jats:p><jats:p>Clinicians should discuss sexual health with all women with breast cancer and survivors of the disease.</jats:p><jats:p>Women with breast cancer often experience premature menopause, which causes greater intensity and duration of symptoms than women undergoing natural menopause.</jats:p><jats:p>Hot flashes, vaginal dryness, urogenital atrophy, dyspareunia, decreased libido, and changes in sexual response have been shown to negatively affect quality of life, compliance with medication, and overall outcome.</jats:p><jats:p>Treatment options for sexual dysfunction in women with breast cancer depend on the etiology of the problem and concomitant medical conditions. Some possible treatments include: lubricants, moisturizers, counseling, sex therapy, altering contributing medications, physical therapy for pelvic floor disorders, and mechanical devices/vibrators.</jats:p>
Umfang:	e575-e581
ISSN:	1548-8748 1548-8756
DOI:	10.14694/edbook_am.2015.35.e575